Barriers to achieving glycemic targets: who omits insulin and why? - Wikidata - wikimedia - TriplyDB

Barriers to achieving glycemic targets: who omits insulin and why?

Barriers to achieving glycemic targets: who omits insulin and why?

http://www.wikidata.org/entity/Q42933616

about

Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy.Incorrect Insulin Administration: A Problem That Warrants Attention.Association of Comorbid and Metabolic Factors with Optimal Control of Type 2 Diabetes Mellitus Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology.Pen needle design influences ease of insertion, pain, and skin trauma in subjects with type 2 diabetes.Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association.Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.

P2860

Q35685013-60BC225B-9737-466C-9B4A-FFDBCE37E0DE Q36467606-A4D32088-5591-40A9-A39A-42D92685981E Q36667608-A8A48695-9F24-4439-89CB-BC7B55A9739F Q36926413-2F7FBD94-2DC0-4E06-8E34-B967F63C2A2E Q37521906-CFE0D47B-3E78-4A11-AE40-830A8332412D Q38450262-0E30F88C-8FFC-4A54-A48A-50CED7C18D92 Q39017951-6951441F-D863-4558-801A-0280331BF6B3 Q42371659-4222EF24-0E87-4179-8A81-1F2D98CE42C0

P2860

Barriers to achieving glycemic targets: who omits insulin and why?

http://www.wikidata.org/entity/Q42933616

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Barriers to achieving glycemic targets: who omits insulin and why?

@en

Barriers to achieving glycemic targets: who omits insulin and why?

@nl

type

label

Barriers to achieving glycemic targets: who omits insulin and why?

@en

Barriers to achieving glycemic targets: who omits insulin and why?

@nl

prefLabel

Barriers to achieving glycemic targets: who omits insulin and why?

@en

Barriers to achieving glycemic targets: who omits insulin and why?

@nl

P1433

Q42933616-0B5B9039-71CB-4423-9327-6A2C9194F255

P1476

Q42933616-46B9FDFB-F3E4-4BC2-AA5B-0F187EF8BD36

P2093

Q42933616-1CA3DB44-51F6-4150-A715-B05005942C51

Q42933616-2DB5C503-9501-4C89-B8D1-3E943CE83DBA

P2860

Q42933616-029E1CBD-C476-440E-87BB-BDD6F8C1E107

Q42933616-0C7ABE49-35DA-4057-95C8-33C693D40396

Q42933616-0DC82ECE-240F-4E72-8EA3-49F0534D97B5

Q42933616-14A59E84-BFF2-4FC8-9F9B-664795ABDDE3

Q42933616-1794A522-F417-41B9-AFB7-05B072027704

Q42933616-1836488B-6C91-4C82-A505-4F406602ED30

Q42933616-1C99F82E-1EAA-47C1-8370-F141A87D384F

Q42933616-27498882-0A4D-4526-AA51-B7696B3AA99A

Q42933616-34D56033-670C-44FA-91D4-F7014F26654D

Q42933616-35D05B3D-1B9F-4BAF-9088-79D42713D573

P304

Q42933616-C942BAA1-E885-402B-A920-A058D0A15187

P31

Q42933616-90a1aa28-899f-463c-a197-282eafba81d8

Q42933616-C9D13EED-2603-4A12-9E16-C6BC68427C81

P356

Q42933616-315A6C97-3A9C-4F66-A4FE-8822D72901B2

P407

Q42933616-01FA5168-0AD5-413B-B60A-C40FE5886E72

P433

Q42933616-979CD77F-2361-4A23-BE4F-CC3AF0B5FADF

P478

Q42933616-F9605258-511B-474D-8238-0BE9E1167DC7

P577

Q42933616-996F5218-449D-4F1A-9FBC-1B7CA66BC1A2

P5875

Q42933616-3D7E8787-FB1D-4E03-8BBF-F68582E34E31

P698

Q42933616-1AD96173-A2F1-41BB-B757-4259D4F6CC35

P932

Q42933616-352F690D-B961-4C43-9413-2BEECD31D81F

P356

P1433

P1476

Barriers to achieving glycemic targets: who omits insulin and why?

@en

P2093

Elizabeth A Beverly

http://www.w3.org/2001/XMLSchema#string

Katie Weinger

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Depression and poor glycemic control: a meta-analytic review of the literature

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

Depression and Diabetes

Correlates of insulin injection omission

Effects of enhanced depression treatment on diabetes self-care

Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

P304

450-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-2132

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41148556

http://www.w3.org/2001/XMLSchema#string

P698

20103561

http://www.w3.org/2001/XMLSchema#string

P932

2809300

http://www.w3.org/2001/XMLSchema#string